Benzodiazapine confirmation by LCMS, Spot Urine

Benzodiazepine Confirmation by LC-MS, Spot Urine

Test Name: Benzodiazepine Confirmation by LC-MS, Spot Urine

Sample Type: Spot Urine

Purpose of the Test:
This test is used to confirm the presence of benzodiazepine drugs and their metabolites in urine using Liquid Chromatography–Mass Spectrometry (LC-MS), a highly sensitive and specific analytical technique. It is commonly performed when an initial drug screening test shows a positive result or when accurate identification of specific benzodiazepines is required.

Why is the Test Done?

• Confirm positive benzodiazepine screening results
• Monitor prescribed benzodiazepine therapy
• Detect drug misuse or abuse
• Workplace and forensic drug testing
• Substance abuse treatment monitoring
• Clinical toxicology investigations

Common Benzodiazepines Detected:

• Diazepam
• Lorazepam
• Alprazolam
• Clonazepam
• Temazepam
• Oxazepam
• Midazolam
• Chlordiazepoxide and related metabolites

Methodology:
Liquid Chromatography–Mass Spectrometry (LC-MS)

Preparation:

• No fasting required.
• Inform your healthcare provider about any medications you are taking.

Interpretation:

• Detected/Positive: One or more benzodiazepines or their metabolites are identified.
• Not Detected/Negative: No benzodiazepines detected above the reporting threshold.

Benefits of LC-MS Confirmation:

• High accuracy and specificity
• Differentiates individual benzodiazepines
• Reduces false-positive results
• Suitable for clinical, occupational, and forensic testing

Reporting Time: Typically 3–7 working days (may vary by laboratory).